Gregory Bailey, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), bought 38,000 shares at $148.04 ($5.6M) on 2022-08-19, disclosed to the SEC on 2022-08-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |